{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:57:34Z","timestamp":1792022254003,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.bbrc.2024.150123","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T01:28:18Z","timestamp":1715650098000},"page":"150123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Nuclear-penetrating scleroderma autoantibody inhibits topoisomerase 1 cleavage complex formation"],"prefix":"10.1016","volume":"720","author":[{"given":"Christopher K.","family":"May","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip W.","family":"Noble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Meffre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James E.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150123_bib1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s12016-020-08831-4","article-title":"Clinical treatment options in scleroderma: recommendations and comprehensive review","volume":"62","author":"Zhao","year":"2022","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bbrc.2024.150123_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.autrev.2009.02.018","article-title":"Anti-topoisomerase I autoantibodies in systemic sclerosis","volume":"8","author":"Czompoly","year":"2009","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbrc.2024.150123_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-1-200401060-00010","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.bbrc.2024.150123_bib4","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1002\/art.38390","article-title":"Prediction of pulmonary complications and long-term survival in systemic sclerosis","volume":"66","author":"Nihtyanova","year":"2014","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbrc.2024.150123_bib5","doi-asserted-by":"crossref","first-page":"10514","DOI":"10.1016\/S0021-9258(19)86738-8","article-title":"Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma","volume":"254","author":"Douvas","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150123_bib6","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"American college of Rheumatology ad hoc committee of immunologic testing, evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2024.150123_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0002-9343(97)00023-5","article-title":"Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies","volume":"103","author":"Spencer-Green","year":"1997","journal-title":"Am. J. Med."},{"key":"10.1016\/j.bbrc.2024.150123_bib8","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1126\/science.3003910","article-title":"High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients","volume":"231","author":"Shero","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150123_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0014-5793(86)81117-6","article-title":"Inhibition of topoisomerase I by antibodies in sera from scleroderma patients","volume":"209","author":"Samuels","year":"1986","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.bbrc.2024.150123_bib10","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2024.150123_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.930970","article-title":"Can antinuclear antibodies have a pathogenic role in systemic sclerosis?","author":"Chepy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.150123_bib12","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.20515","article-title":"Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis","volume":"50","author":"H\u00e9nault","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2024.150123_bib13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/art.21646","article-title":"DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti- topoisomerase I autoantibodies from systemic sclerosis patients","volume":"54","author":"H\u00e9nault","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bbrc.2024.150123_bib14","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrrheum.2016.23","article-title":"DNA-damaging autoantibodies and cancer: the lupus butterfly theory","volume":"12","author":"Noble","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.bbrc.2024.150123_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004385","article-title":"Targeting cancer with a lupus autoantibody","volume":"4","author":"Hansen","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bbrc.2024.150123_bib16","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-14-2278","article-title":"Optimizing a lupus autoantibody for targeted cancer therapy","volume":"75","author":"Noble","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2024.150123_bib17","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bbrc.2018.01.139","article-title":"Re-engineering and evaluation of anti-DNA autoantibody 3E10 for therapeutic applications","volume":"496","author":"Rattray","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.150123_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/srep12022","article-title":"DNA-dependent targeting of cell nuclei by a lupus autoantibody","volume":"5","author":"Weisbart","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150123_bib19","doi-asserted-by":"crossref","first-page":"20790","DOI":"10.1074\/jbc.C700090200","article-title":"Intranuclear protein transduction through a nucleoside salvage pathway","volume":"282","author":"Hansen","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150123_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145875","article-title":"ENT2 facilitates brain endothelial cell penetration and blood-brain barrier transport by a tumor-targeting anti-DNA autoantibody","author":"Rattray","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.bbrc.2024.150123_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/art.41927","article-title":"Defective early B cell tolerance checkpoints in patients with systemic sclerosis allow the production of self antigen-specific clones","volume":"74","author":"Glauzy","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.bbrc.2024.150123_bib22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1469-7793.1999.00709.x","article-title":"Inhibition of Na(+)\u2212H(+) exchange impairs receptor-mediated albumin endocytosis in renal proximal tubule-derived epithelial cells from opossum","volume":"520","author":"Gekle","year":"1999","journal-title":"J. Physiol."},{"key":"10.1016\/j.bbrc.2024.150123_bib23","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.devcel.2006.04.002","article-title":"Dynasore, a cell-permeable inhibitor of dynamin","volume":"10","author":"Macia","year":"2006","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbrc.2024.150123_bib24","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4161\/cl.23967","article-title":"Search for inhibitors of endocytosis: intended specificity and unintended consequences","volume":"2","author":"Dutta","year":"2012","journal-title":"Cell. Logist."},{"key":"10.1016\/j.bbrc.2024.150123_bib25","doi-asserted-by":"crossref","first-page":"17250","DOI":"10.1074\/jbc.270.29.17250","article-title":"Cellular cholesterol efflux mediated by cyclodextrins","volume":"270","author":"Kilsdonk","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150123_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1091\/mbc.10.4.961","article-title":"Extraction of cholesterol with methyl-beta-cyclodextrin perturbs formation of clathrin-coated endocytic vesicles","volume":"10","author":"Rodal","year":"1999","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.bbrc.2024.150123_bib27","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/0014-4827(90)90247-8","article-title":"Plant DNA topoisomerase I is recognized and inhibited by human Scl-70 sera autoantibodies","volume":"189","author":"Agris","year":"1990","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bbrc.2024.150123_bib28","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1016\/S0021-9258(19)69324-5","article-title":"DNA is linked to the rat liver DNA nicking-closing enzyme by a phosphodiester bond to tyrosine","volume":"256","author":"Champoux","year":"1981","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2024.150123_bib29","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1073\/pnas.86.10.3559","article-title":"Peptide sequencing and site-directed mutagenesis identify tyrosine-727 as the active site tyrosine of Saccharomyces cerevisiae DNA topoisomerase I","volume":"86","author":"Lynn","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2024.150123_bib30","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0092-8674(90)90724-S","article-title":"Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities","volume":"60","author":"Stewart","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150123_bib31","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0092-8674(85)80027-1","article-title":"A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin","volume":"41","author":"Bonven","year":"1985","journal-title":"Cell"},{"issue":"3 3","key":"10.1016\/j.bbrc.2024.150123_bib32","article-title":"Topoisomerase assays","volume":"3","author":"Nitiss","year":"2012","journal-title":"Curr. Protoc. Pharmacol."},{"key":"10.1016\/j.bbrc.2024.150123_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.904631","article-title":"Effects of immunoglobulins G from systemic sclerosis patients in normal dermal fibroblasts: a multi-omics study","author":"Chepy","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2024.150123_bib34","doi-asserted-by":"crossref","first-page":"19287","DOI":"10.1016\/S0021-9258(17)30656-7","article-title":"Irreversible trapping of the DNA-topoisomerase I covalent complex, Affinity labeling of the camptothecin binding site","volume":"265","author":"Hertzberg","year":"1990","journal-title":"J. Biol. Chem."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24006594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24006594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T05:38:28Z","timestamp":1717738708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24006594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":34,"alternative-id":["S0006291X24006594"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150123","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nuclear-penetrating scleroderma autoantibody inhibits topoisomerase 1 cleavage complex formation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150123","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"150123"}}